Insight Molecular Diagnostics
IMDX
#8737
Rank
NZ$0.26 B
Marketcap
NZ$9.29
Share price
0.18%
Change (1 day)
47.06%
Change (1 year)

Market capitalization of Insight Molecular Diagnostics (IMDX)

Market cap: NZ$0.26 Billion

As of March 2026 Insight Molecular Diagnostics has a market cap of NZ$0.26 Billion. This makes Insight Molecular Diagnostics the world's 8737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insight Molecular Diagnostics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.26 B-28.2%
2025NZ$0.37 B404%
2024NZ$73.65 M125.54%
2023NZ$32.65 M-45.54%
2022NZ$59.96 M-79.53%
2021NZ$0.29 B27.99%
2020NZ$0.22 B20.16%
2019NZ$0.19 B127.75%
2018NZ$83.65 M-59.34%
2017NZ$0.20 B-29.58%
2016NZ$0.29 B26.02%
2015NZ$0.23 B

End of Day market cap according to different sources

On Mar 5th, 2026 the market cap of Insight Molecular Diagnostics was reported to be:

NZ$0.26 Billion
by Nasdaq info icon info icon
NZ$0.26 Billion
by CompaniesMarketCap info icon info icon